AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME
Clinical trials for AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME trials appear
Sign up with your email to follow new studies for AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare immune disorder: drug targets swollen organs
Disease control Recruiting nowThis study tests a drug called soquelitinib in 15 people aged 16 and older with autoimmune lymphoproliferative syndrome (ALPS), a rare condition where the body stores too many immune cells, causing enlarged spleen and lymph nodes. The drug is taken as a tablet twice daily for one…
Matched conditions: AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 26, 2026 10:23 UTC
-
New study aims to crack the code of autoimmune diseases
Knowledge-focused Recruiting nowThis study is creating a tool to help doctors diagnose and choose treatments for autoimmune diseases. Researchers will analyze blood and other samples from 500 children with autoimmune conditions and healthy children to find patterns in genes and proteins. The goal is to better u…
Matched conditions: AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC